¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acute subdural hemorrhage"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • acute intermittent porphyria
    ±Þ¼º °£Ç漺(Ðáàõ ÊàúÎàõ) Æ÷¸£ÇǸ°Áõ(~ ñø)
  • acute intermitternt porphyria
    ±Þ¼º °£Ç漺 Æ÷¸£ÇǸ®¾Æ(Áõ)
  • acute interstitial pneumonitis
    ±Þ¼º °£Áú¼º Æó·Å(¡­ÊàòõàõøËæú).
  • acute intussusception
    ±Þ¼º ÀåÁßø(Áõ).
  • acute labyrinthitis
    ±Þ¼º ¹Ì·Î¿°, ¡­³»ÀÌ¿°
  • acute lacunar tonsillitis
    ±Þ¼º ¼±¿ÍÆíµµ¿°
  • acute laryngitis
    ±Þ¼º Èĵο°
  • acute laryngotracheal trauma
    ±Þ¼º Èĵαâ°ü¿Ü»ó
  • acute laryngotracheobronchitis
    ±Þ¼º Èĵαâ°üÁö¿°
  • acute leukemia
    ±Þ¼º ¹éÇ÷º´(¡­ÛÜúìÜ»).
  • acute monocytic leukemia
    ±Þ¼º ´Ü±¸(¼º) ¹éÇ÷º´(?ËÀË´ËÛËÑÌ´ËÓ).
  • acute myeloblastic leukemia
    ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´.
  • acute myeloblastic leukemia
    ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´.
  • acute myelocytic leukemia =AML
    ±Þ¼º °ñ¼ö±¸¼º ¹éÇ÷º´.
  • acute myelogenous leukemia
    ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´(¡­ÍéâÐàõÛÜúìÜ»).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • umbilical hemorrhage
    Á¦ÃâÇ÷(ð°õóúì)
  • uveitis-glaucoma-hemorrhage syndrome
    Æ÷µµ¸·¿°³ì³»ÀåÃâÇ÷ÁõÈıº
  • venous hemorrhage
    Á¤¸Æ¼ºÃâÇ÷(¡­ÃâÇ÷).
  • venous hemorrhage
    Á¤¸Æ¼ºÃâÇ÷(¡­õóúì)
  • vicarious hemorrhage
    ´ë»ó¼º ÃâÇ÷.
  • vicarious hemorrhage
    ´ë»ó¼º ÃâÇ÷(¡­ õóúì)
  • vitreous hemorrhage
    À¯¸®Ã¼ÃâÇ÷(¡­õóúì).
  • vitreous hemorrhage
    ÃÊÀÚüÃâÇ÷(¡­õóúì)
  • acute mixed-lineage leukmia
    ±Þ¼º È¥ÇÕÁ÷°è¼º ¹éÇ÷º´
  • acute abdomen =abdominal emergencies
    ±Þ¼ºº¹Áõ(¡­º¹Áõ).
  • acute abdomen =abdominal emergencies
    ¼Ò¾Æ°ú ±Þ¼ºº¹Áõ(¡­ÜÙñø).
  • acute alcoholism
    ±Þ¼º ¾ËÄÚ¿ÃÁßµ¶(Áõ).
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • acute anterior poliomyelitis
    ±Þ¼ºÀü°¢¼ºÈ¸¹é¼ö¿°, Æú¸®¿À
  • acute anterior poliomyelitis =infantile par aly sis
    ±Þ¼º ȸ¹éô¼ö¿°(ÐáàõüéÛÜô±âÐæú).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
IRH Institute for Research in Hypnosis; Institute of Religion and Health; intrarenal hemorrhage
IVH intravenous hyperalimentation; intraventricular hemorrhage; in vitro hyperploidy
LPPH late postpartum hemorrhage
MVH massive vitreous hemorrhage
PIH periventricular-intraventricular hemorrhage; phenyl isopropylhydrazine; pregnancy-induced hypertensi...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
APACHE II Acute Physiology and Chronic Health Evaluation II
APMPPE Acute Posterior Multifocal Placoid Pigment Epitheliopathy
APSGN Acute Poststreptococcal Glomerulonephritis
APL Acute Promyelocytic Leukaemia
AR Acute Rejection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute rheumatic arthritis
    ±Þ¼º ·ù¸¶Æ¼½º¼º °üÀý¿°
  • acute rheumatic polyarthritis
    ±Þ¼º ·ù¸¶Æ¼½º¼º ´Ù¹ß °üÀý¿°, ±Þ¼º ·ù¸¶Æ¼½º¼º ´Ù¹ß¼º °üÀý¿°
  • acute rhinitis
    ±Þ¼º ºñ¿°
    ÄÚ¿¡ »ý±â´Â ±Þ¼º ¿°Áõ.
  • acute serum sickness
    ±Þ¼º Ç÷ûº´
    Àü½Å¼º ¸é¿ªº¹ÇÕü ÁúȯÀÇ ÀüÇüÀûÀÎ ¿¹ÀÌ´Ù. Çѵ¿¾È Çǵ¿¼º ¸é¿ªÀ» À§ÇØ »ç¿ëµÈ ´Ù·®ÀÇ ÀÌÁ¾ Ç÷ûÀÇ Åõ¿©¿¡ µû¸¥ ÈÄÀ¯ÁõÀÌ´Ù.
  • acute situational stress reaction
    ±Þ¼º »óȲ¼º ½ºÆ®·¹½º ¹ÝÀÀ
    ±ØµµÀÇ È¯°æÀû ½ºÆ®·¹½º¿¡ ´ëÇÑ ÀϽÃÀûÀÎ ¹ÝÀÀÀ¸·Î ±âÃÊÀûÀÎ Á¤½Å Àå¾Ö°¡ ¾ø´Â °³Àο¡°Ô ³ªÅ¸³­´Ù.
  • acute stage
    ±Þ¼º±â
    º´Àû °æ°ú¿¡ À־ ±Þ¼º »óÅ¿¡ ¸Ó¹«´Â ±â°£.
  • acute sublingual sialadenitis
    ±Þ¼º ¼³Çϼ±¿°
  • acute suppurative osteomyelitis
    ±Þ¼º È­³ó¼º °ñ¼ö¿°
    °ñ¼ö¿¡ »ý±â´Â °í¸§À» ¸¸µå´Â ±Þ¼º ¿°Áõ.
  • acute suppurative periodontitis
    ±Þ¼º È­³ó¼º Ä¡ÁÖ¿°
  • acute TMJ sprain
    ±Þ¼º ¾Ç°üÀý ¿°ÁÂ
  • acute toxicity
    ±Þ¼º Áßµ¶, ±Þ¼º µ¶¼º
  • acute tuberculous pneumonia
    ±Þ¼º °áÇÙ¼º Æó·Å
    °áÇÙÀÌ °¨¿°µÇ¾î º¸Åë ¸¸¼º À°¾ÆÁ¾¼º ¿°ÁõÀ» ¾ß±âÇÏ´Â ÀϹÝÀûÀÎ °æ¿ì¿Í ´Þ¸® ±Þ¼º Æó·Å°ú °°ÀÌ ±Þ¼º »ïÃ⼺ ¿°ÁõÀ¸·Î ³ªÅ¸³ª´Â °æ¿ì·Î¼­ ÀúÇ×·ÂÀÌ ¾àÇÑ »ç¶÷¿¡°Ô º¼ ¼ö ÀÖ´Ù.
  • acute ulcerative gingivitis
    ±Þ¼º ±Ë¾ç¼º Ä¡Àº¿°
    ¹æÃß»ó ±Õ°ú ³ª¼±Çü ±Õ¿¡ ÀÇÇÑ Æ¯ÀÌÇÑ ÇüÅÂÀÇ Ä¡Àº¿°À¸·Î 15-30¼¼ÀÇ ¿¬·ÉÃþ¿¡¼­ È£¹ßÇϸç À¯¸®Ä¡Àº º¯¿¬ºÎ, Ä¡°£À¯µÎ¿¡ ±«»ç ¹× ±Ë¾çÀ» ÃÊ·¡Çϰí, µ¿Åë, ±Çۨ, ºÒÄè°¨À» È£¼ÒÇϸç, ¾ÇÃ븦 À¯¹ßÇÑ´Ù.
  • acute urticaria
    ±Þ¼º µÎµå·¯±â, ±Þ¼º ´ã¸¶Áø
  • acute Vincent's infection
    ±Þ¼º ºó¼¾Æ®¾¾ ±Ë¾ç¼º °¨¿°, ±Þ¼º ºó¼¾Æ® °¨¿°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 11
oesophageal stricture, acute A narrowing or closure of the normal opening of the swallowing tube leading to the stomach, usually caused by scarring from acid irritation. Acute, complete obstruction of the oesophagus occurs when food (usually meat) is lodged in the oesophageal stricture. Patients experience chest pain, and are unable to swallow saliva. Attempts to relieve the obstruction by inducing vomiting at home are usually unsuccessful. Patients with complete oesophageal obstruction can breathe, and are not at any risk of suffocation. Endoscopy is usually employed to retrieve the meat and relieve the obstruction.
(12 Dec 1998)
encephalomyelitis, acute disseminated An acute or subacute encephalomyelitis or myelitis characterised by perivascular lymphocyte and mononuclear cell infiltration and demyelination. It occurs most commonly following an acute viral infection, especially measles, but may occur without a recognizable antecedent, and formerly occurred as a complication of rabies and smallpox vaccination.
(12 Dec 1998)
kidney failure, acute A clinical syndrome characterised by a sudden decrease in glomerular filtration rate, often to values of less than 1 to 2 ml per minute. It is usually associated with oliguria (urine volumes of less than 400 ml per day) and is always associated with biochemical consequences of the reduction in glomerular filtration rate such as a rise in blood urea nitrogen (bun) and serum creatinine concentrations.
(12 Dec 1998)
kidney tubular necrosis, acute Acute kidney failure resulting from destruction of tubular epithelial cells. It is commonly attributed to exposure to toxic agents or renal ischemia following severe trauma.
(12 Dec 1998)
leukaemia, erythroblastic, acute A myeloproliferative disorder characterised by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
(12 Dec 1998)
leukaemia, megakaryocytic, acute Nonlymphocytic leukaemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. Myelofibrosis or increased bone marrow reticulin is common.
(12 Dec 1998)
leukaemia, myelocytic, acute Progressive, malignant disease of the myeloid tissue in which the granular, polymorphonuclear leukocytes and their precursors predominate.
(12 Dec 1998)
leukaemia, nonlymphocytic, acute Acute leukaemia distinguished from acute lymphocytic leukaemia (all) by the morphology of the marrow and blood leukaemic cells. Cytoplasmic granules are usually present and the nucleus is usually large and irregular. Anll is more common in adults than all and occurs at any age.
(12 Dec 1998)
leukoencephalitis, acute haemorrhagic A rare, fatal postinfection or allergic demyelinating disease of the central nervous system having a fulminating course and occurring mainly in young adults. It is characterised by destruction of white matter to the point of liquefaction; widespread necrosis of blood vessel walls leading to the formation of multiple small haemorrhages in the involved areas and the exudation of fibrin into the surrounding tissue; and cellular infiltration of the necrotic areas.
(12 Dec 1998)
liver failure, acute A form of liver failure with rapid onset. It is often induced by the toxic effect of drugs and various toxic substances in experimental studies in animals and in clinical states in humans. If coma ensues, the constellation of neurological symptoms is referred to as hepatic encephalopathy.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á